Single-Dose Treatment Option Approved for Skin Infection Drug Dalvance


The FDA has approved Allergan's supplemental new drug application to update the label for dalbavancin (Dalvance).

The FDA has approved Allergan’s supplemental new drug application to update the label for dalbavancin (Dalvance).

The expanded label will allow for single-dose treatments administered as a 30-minute IV infusion to treat acute bacterial skin and skin structure infections caused by Gram-positive bacteria in adults.

Dalvance may be used to treat infections caused by methicillin-resistant Staphylococcus aureus.

"Hospitals are facing pressures to reduce hospitalizations and readmissions, while maintaining quality of care and patient outcomes," said David Talan, chairman emeritus of the Department of Emergency Medicine and Faculty at the Division of Infectious Diseases, Olive View-UCLA Medical Center, in a press release. "The single-dose regimen for Dalvance will allow for delivery of IV antibiotic in 30 minutes in the emergency department and infusion centers and will provide selected patients the benefit of receiving a complete course of parenteral treatment, which may allow for avoiding hospital admission."

The FDA approved the application after reviewing results from a phase 3 study, which showed Dalvance’s effectiveness in single-dose form. The drug met its primary endpoint of non-inferiority compared with a 2-dose regimen.

After 48 to 72 hours following therapy, patients saw a decrease of at least 20% in the lesion area compared with the baseline measurement.

The most common adverse effects of Dalvance include nausea, diarrhea, vomiting, headache, rash, and itchiness.

"Allergan is committed to further research and development of Dalvance and our entire anti-infective portfolio to help improve clinical outcomes for patients,” said David Melnick, vice president of Clinical Development for the Anti-Infectives sector of Allergan, in a press release.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii |
Pharmacy Interior | Image Credit: Tyler Olson -
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi -
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen |
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/ |
Image credit: fidaolga -
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund |
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi -
© 2023 MJH Life Sciences

All rights reserved.